ISLA-101 Phase 2a/b PROTECT Clinical Trial Progress Update
Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on...
Read moreAustralian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on...
Read moreLightning Minerals (L1M or the Company) is delighted to announce the discovery of spodumene within a lithium bearing pegmatite at...
Read moreProvaris Energy Ltd (ASX.PV1, Provaris, the Company) is pleased to present the notice of initial substantial holder. Click here for...
Read moreIran’s foreign ministry denied that a meeting was held between the Iranian ambassador to the United Nations and Elon Musk,...
Read moreThe bad news keeps coming. Wherever Kyiv looks, Moscow seems to have the advantage. Russia is making gains at key...
Read moreIntense Israeli strikes targeted areas of Beirut’s southern suburbs Saturday as the Lebanese militant group Hezbollah considered its response to...
Read moreMore than half a million people have been evacuated from their homes as Super Typhoon Man-yi made landfall along the...
Read moreThe head of Georgia’s Central Electoral Commission was doused with black paint Saturday at a meeting to confirm the results...
Read moreDozens of people detained during protests over Venezuela’s disputed presidential election have been released, according to the local rights group...
Read moreA foul-mouthed former Philippine president who jailed political rivals, insulted the pope and claims to have hired “death squad” gangsters...
Read moreDisclaimer: financemasterynews.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.